CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV)
CUSIP: 18914F103
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 416,598,522
- Total 13F shares
- 125,586,630
- Share change
- -9,687,917
- Total reported value
- $295,177,667
- Put/Call ratio
- 67%
- Price per share
- $2.35
- Number of holders
- 189
- Value change
- -$29,007,657
- Number of buys
- 83
- Number of sells
- 93
Quarterly Holders Quick Answers
What is CUSIP 18914F103?
CUSIP 18914F103 identifies CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 18914F103:
Top shareholders of CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.2%
from 13D/G
|
30,394,942
|
$93,008,521 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.5%
|
23,060,008
|
$70,563,625 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
9,720,407
|
$29,748,609 | — | 30 Sep 2025 | |
| Chamath Palihapitiya |
3/4/5
|
FORMER CHIEF EXECUTIVE OFFICER AND DIRECTOR, 10%+ Owner |
—
class O/S missing
|
30,147,610
|
$29,544,657 | — | 07 Jul 2021 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
8,951,676
|
$27,392,129 | — | 30 Sep 2025 | |
| GREENOAKS CAPITAL PARTNERS LLC |
3/4/5
|
Other*, 10%+ Owner |
—
class O/S missing
|
25,754,556
|
$24,466,828 | — | 22 Nov 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.9%
|
7,712,700
|
$23,600,862 | — | 30 Sep 2025 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
1.1%
|
4,463,811
|
$13,659,262 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1%
|
4,271,515
|
$13,070,836 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.81%
|
3,373,192
|
$10,321,968 | — | 30 Sep 2025 | |
| Divisadero Street Capital Management, LP |
13F
|
Company |
0.66%
|
2,768,088
|
$8,470,349 | — | 30 Sep 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.65%
|
2,701,896
|
$8,267,802 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.55%
|
2,282,113
|
$6,983,266 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.51%
|
2,140,282
|
$6,551,257 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.48%
|
2,013,401
|
$6,161,009 | — | 30 Sep 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.47%
|
1,966,588
|
$6,017,759 | — | 30 Sep 2025 | |
| Scott J. Leffler |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
4,857,303
|
$4,760,157 | — | 25 Jan 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.36%
|
1,487,650
|
$4,552,209 | — | 30 Sep 2025 | |
| Soviero Asset Management, LP |
13F
|
Company |
0.34%
|
1,400,000
|
$4,284,000 | — | 30 Sep 2025 | |
| GMT CAPITAL CORP |
13F
|
Company |
0.31%
|
1,305,200
|
$3,993,912 | — | 30 Sep 2025 | |
| Aric R. Sharp |
3/4/5
|
CEO of Value Based Care |
—
class O/S missing
|
2,100,665
|
$3,907,237 | — | 09 Aug 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.3%
|
1,237,171
|
$3,785,743 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.29%
|
1,193,626
|
$3,652,495 | — | 30 Sep 2025 | |
| CLOVER HEALTH INVESTMENTS, CORP. /DE |
3/4/5
|
Chief Technology Officer |
—
class O/S missing
|
3,093,225
|
$3,031,361 | — | 31 Oct 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.23%
|
957,957
|
$2,931,349 | — | 30 Sep 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.21%
|
883,536
|
$2,703,620 | — | 30 Sep 2025 | |
| Joseph R. Martin |
3/4/5
|
General Counsel |
—
class O/S missing
|
2,718,857
|
$2,664,480 | — | 14 Jun 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.21%
|
866,410
|
$2,651,214 | — | 30 Sep 2025 | |
| IMC-Chicago, LLC |
13F
|
Company |
0.21%
|
859,913
|
$2,631,334 | — | 30 Sep 2025 | |
| JUPITER ASSET MANAGEMENT LTD |
13F
|
Company |
0.2%
|
850,884
|
$2,603,705 | — | 30 Sep 2025 | |
| Atom Investors LP |
13F
|
Company |
0.2%
|
826,591
|
$2,529,368 | — | 30 Sep 2025 | |
| Swiss National Bank |
13F
|
Company |
0.19%
|
807,600
|
$2,471,256 | — | 30 Sep 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.18%
|
748,935
|
$2,291,741 | — | 30 Sep 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.17%
|
702,981
|
$2,151,121 | — | 30 Sep 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.16%
|
664,630
|
$2,033,768 | — | 30 Sep 2025 | |
| Chelsea Clinton |
3/4/5
|
Director |
—
class O/S missing
|
602,814
|
$1,983,258 | — | 06 Jan 2025 | |
| TEACHER RETIREMENT SYSTEM OF TEXAS |
13F
|
Company |
0.16%
|
647,176
|
$1,980,359 | — | 30 Sep 2025 | |
| Lee Shapiro |
3/4/5
|
Director |
—
class O/S missing
|
598,622
|
$1,969,466 | — | 06 Jan 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.15%
|
624,470
|
$1,910,000 | — | 30 Sep 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.14%
|
600,777
|
$1,838,378 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.14%
|
577,952
|
$1,768,533 | — | 30 Sep 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.14%
|
570,788
|
$1,746,600 | — | 30 Sep 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.13%
|
526,858
|
$1,612,185 | — | 30 Sep 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.12%
|
485,433
|
$1,485,425 | — | 30 Sep 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.1%
|
436,810
|
$1,336,639 | — | 30 Sep 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.1%
|
415,985
|
$1,272,914 | — | 30 Sep 2025 | |
| Nathaniel S. Turner |
3/4/5
|
Director |
—
class O/S missing
|
1,324,728
|
$1,258,492 | — | 07 Jan 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.1%
|
400,908
|
$1,226,778 | — | 30 Sep 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.09%
|
389,835
|
$1,192,895 | — | 30 Sep 2025 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.09%
|
376,659
|
$1,152,577 | — | 30 Sep 2025 |
Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q4 2025
As of 31 Dec 2025,
CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) was held by
189 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
125,586,630 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, RENAISSANCE TECHNOLOGIES LLC, PNC Financial Services Group, Inc., DIMENSIONAL FUND ADVISORS LP, NORTHERN TRUST CORP, and MORGAN STANLEY.
This page lists
189
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
199
Q4 2025 holders
189
Holder diff
-10
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.